Pinnacle Wealth Management Advisory Group, LLC
Position in EXEL — Exelixis, Inc.
CIK 1631864
RED BANK, NJ
Position in EXEL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$261,222
+$38,409 QoQ
Shares Held
4,801
-7.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#544
of 754 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pinnacle Wealth Management Advisory Group, LLC holds $3,356,791 across 9 Biotechnology names. EXEL ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,713 | $1,691,664 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,248 | $619,919 | |
| 3 | INCY |
Incyte Corp
|
3,189 | $361,505 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
4,801 | $261,222 | |
| 5 | ABVX |
Abivax S.A.
|
1,864 | $248,396 | |
| 6 | GERN |
Geron Corp
|
44,287 | $56,687 | |
| 7 | ABOS |
Acumen Pharmaceuticals, Inc.
|
18,020 | $48,113 | |
| 8 | BCYC |
Bicycle Therapeutics PLC
|
10,985 | $46,576 |
All Filings in EXEL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $261,222 | 4,801 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $222,813 | 5,195 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $279,153 | 6,369 | Shares | Sole | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||